Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor

Biophysical Journal

Volumn 98, Issue 8, 2010, Pages 1494-1502

  Lochner, M ^a   Lummis, S C R ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951635347     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.12.4313     Document Type: Article

References (37)

1. Reeves, D. C., and S. C. R. Lummis. 2002. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol. Membr. Biol. 19:11-26.
2. Collingridge, G. L., R. W. Olsen,..., M. Spedding. 2009. A nomenclature for ligand-gated ion channels. Neuropharmacology. 56:2-5.
3. 3B subunit is a major determinant of serotonin-receptor function. Nature. 397: 359-363.
4. 3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene. 310:101-111.
5. 3 receptors in rodents. J. Neurochem. 75:240-247.
6. 3 receptors. Proc. Natl. Acad. Sci. USA. 102:12595-12600.
7. 3B receptor subunit. J. Biol. Chem. 274:30799-30810.
8. 3 receptor. Biophys. J. 84:1720-1733.
9. 3 receptors. Nature. 424:321-324.
10. 3) receptor reveals a novel determinant of singlechannel conductance. Biochem. Soc. Trans. 32:547-552.
11. 3 receptor. Trends Pharmacol. Sci. 26:587-594.
12. 2 nicotinic acetylcholine receptors. J. Biol. Chem. 281:8062-8071.
13. Brejc, K., W. J. van Dijk,..., T. K. Sixma. 2001, Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 411:269-276. (Pubitemid 32467026)
14. 3 receptor agonist-binding residues using homology modeling. Biophys. J. 84:2338-2344.
15. Joshi, P. R., A. Suryanarayanan, ..., Z. Bikádi. 2006. Interactions of granisetron with an agonist-free 5-HT3A receptor model. Biochemistry. 45:1099-1105.
16. 3A receptor models. J. Recept. Signal Transduct. Res. 23:255-270.
17. 3 receptor. Mol. Pharmacol. 68:365-371.
18. Tremblay, P. B., R. Kaiser,..., J. Brockmoller. 2003. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J. Clin. Oncol. 21: 2147-2155.
19. 3 receptor binding site using modeling and radioligand binding. J. Biol. Chem. 280:20476-20482.
20. Shi, J., T. L. Blundell, and K. Mizuguchi. 2001. FUGUE: sequencestructure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J. Mol. Biol. 310: 243-257. (Pubitemid 32619966)
21. Sali, A., and T. L. Blundell. 1993. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779-815.
22. Chen, C. A., and H. Okayama. 1988. Calcium, phosphate-mediated gene transfer: a highly efficient transfection system for stably transfonning cells with plasmid DNA. Biotechniques. 6:632-638.
23. Jordan, M., A. Schallhom, and F. M. Wurm. 1996. Transfecting mammalian cells: optimization of critical parameters affecting calciumphosphate precipitate formation. Nucleic Acids Res. 24:596-601. (Pubitemid 26085833)
24. + channel determined by construction of multimeric cDNAs. Neuron. 9:861-871.
25. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82: 488-492.
26. Price, K. L., and S. C. R, Lummis. 2004. The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor. J. Biol. Chem. 279:23294-23301.
27. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Turchin, A., and J. F. Lawler, Jr. 1999. The primer generator: a program that facilitates the selection of oligonucleotides for site-directed mutagenesis. Biotechniques. 26:672-676.
29. Bylund, D. B., and M. L. Toews. 1993. Radioligand binding methods: practical guide and tips. Am. J. Physiol. 265:L421-L429.
30. 3 receptor label both native and recombinant receptors. Brain Res. Mol. Brain Res. 71:369.
31. 3B receptor subunits by anti-peptide polyclonal antibodies. BMC Neurosci. 7:27-34.
32. 3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry. 41:10262-10269.
33. Das, P., and G. H. Dillon. 2005. Molecular determinants of Picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. J. Pharmacol. Exp. Ther. 314:320-328. (Pubitemid 41058269)
34. c) receptors. Br. J. Pharmacol. 153:1686-1696.
35. C receptor: the role of Arg 104. Biophys. J. 95:4115-4123.
36. Mu, T. W., H. A. Lester, and D. A. Dougherty. 2003. Different binding orientations for the same agonist at homologous receptors: a lock and key or a simple wedge? J. Am. Chem. Soc. 125:6850-6851.
37. 3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide. Biochemistry. 44:9140-9149.